** Shares of infusion therapy services provider Option Care Health OPCH.O rise 2.03% to $33.3 premarket
** Co forecasts 2025 revenue in the range of $5.3 bln to $5.5 bln and profit between $1.59 to $1.69/share, higher than analysts' estimate of $5.26 bln and $1.25/share, respectively, as per data compiled by LSEG
** Co posts Q4 revenue of $1.35 bln, beating analyst estimates of $1.29 bln
** Co reports Q4 profit of 35 cents/share, vs analyst est of 34 cents/share
** Stock has risen 4.3% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。